Flywheel, a research data platform designed for the academic, clinical and life science communities, has announced its launch of Flywheel for Life Sciences. Flywheel for Life Sciences is an enterprise-scale research data management solution helping organizations realize their digital transformation strategy and improve R&D efficiency.
A digital transformation is underway in the life sciences and organizations are motivated to reduce R&D costs, improve operational efficiencies and shorten drug development timelines. To be successful, these organizations need to cost-effectively leverage high-quality data for the exploration of new solutions and reuse data collaboratively within data science & research teams. However, traditional R&D infrastructures are insufficient for large-scale data collection, complex data validation, automated quality controls, and scaling processing (and AI) pipelines.
Flywheel offers a scalable research-first platform that can capture imaging and related data from multiple siloed sources, including CROs and historical clinical trials. Flywheel integrates with existing data pipelines and software tools to ingest multi-modal data, and then consolidate, curate, validate, and disseminate that data to analytics and machine learning platforms. With the provenance to support regulatory approvals and scientific reproducibility, Flywheel supports secure collaboration to solve problems with multi-disciplinary teams internal and external to organizations.
Now with Flywheel for Life Sciences, the solution incorporates new enterprise scaling features that help support the needs of large, global life sciences organizations and their massive volumes of data from diverse sources all over the world. These features include high speed bulk loading, horizontal and vertical scaling, version control deployments, and the provenance to support audit readiness.
Flywheel leverages the full power of modern cloud computing to deliver the performance and reliability needed in the life sciences. Flywheel offers enterprise deployments on major providers such as Amazon Web Services, Google Cloud, and Microsoft Azure. Flywheel for Life Sciences is delivered as a fully managed service allowing digital, operations, data, and clinical teams to focus on research and results rather than IT.
With expertise in medical imaging and computer science, the Flywheel team partners with life sciences organizations to tailor and deliver a system that meets enterprise requirements and critical schedules.
"We are excited to launch our Life Sciences solution to streamline and leverage imaging data assets and machine learning workflows, helping organizations increase R&D efficiency and accelerate drug discovery," said Travis Richardson, Chief Product Officer of Flywheel.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
FDA Outlines Updated Requirement for Placebo-Controlled Trials in Vaccine Research
May 21st 2025In an article recently published by The New England Journal of Medicine, FDA higher-ups Vinay Prasad, MD, MPH; and Martin A. Makary, MD, MPH, wrote that any new COVID-19 vaccine must now be evaluated in placebo-controlled studies.